Organ Donor with Rabies Had Raccoon BitesBioscience TechnologyAn Air Force recruit whose organs were donated to four patients, including a kidney recipient who died of rabies, had at least two untreated raccoon bites several months before he became sic…
Harbour Antibodies BV Raises €2.5M ($3.3M) to Accelerate the Development of … – PipelineReview.com (press release)
|
Harbour Antibodies BV Raises €2.5M ($3.3M) to Accelerate the Development of …
PipelineReview.com (press release) ROTTERDAM, The Netherlands & CAMBRIDGE, MA, USA I July 24, 2013 I Harbour Antibodies BV, the creator of transgenic mice to aid in the discovery of new human antibody-based therapies, has raised €2.5M ($3.3M) to continue R&D and commercialize … |
Here's Your iHeartRadio for People Who Actually Heart Talk Radio – Gizmodo India
|
Here’s Your iHeartRadio for People Who Actually Heart Talk Radio
Gizmodo India iHeartRadio is the free streaming audio service of choice primarily for people who love terrestrial radio, and want to be able to get their local channels over the web. (Yes! Millions of these crazy people exist.) But until now, the service has lacked … |
Two decades after Canada's tainted-blood inquiry, new blood donation rules … – Vancouver Sun
Vancouver Sun |
Two decades after Canada’s tainted-blood inquiry, new blood donation rules …
Vancouver Sun MONTREAL – A new blood-donation policy came into effect across Canada on Monday, officially nixing the lifelong ban that prevented men who have had sex with men from giving blood. Canadian Blood Services and HEMA-Quebec — which oversee … 20 years after tainted-blood inquiry, new blood donation rules take effectYahoo! News Canada Health benefits of donating bloodJamaica Gleaner |
Harbour Antibodies BV Raises €2.5M ($3.3M) to Accelerate the Development of … – Fort Mills Times
|
Harbour Antibodies BV Raises €2.5M ($3.3M) to Accelerate the Development of …
Fort Mills Times Harbour Antibodies BV, the creator of transgenic mice to aid in the discovery of new human antibody-based therapies, has raised €2.5M ($3.3M) to continue R&D and commercialize its technologies. The round was led by Atlas Venture. With the funding … Harbour Antibodies Licenses H2L2 Mice to PfizerPharmiWeb.com (press release) Atlas leads €2.5m round for Harbour Antibodiesunquote news (subscription) Pfizer licenses antibody tech from Atlas-backed startup HarbourFierceBiotech |
Two decades after tainted-blood inquiry, new blood donation rules take effect … – Ottawa Citizen
Ottawa CitizenTwo decades after tainted-blood inquiry, new blood donation rules take effect …Ottawa CitizenA man gives blood in Montreal, on November 29, 2012. A new blood-donation policy came into effect across Canada on Monday, officially nixing th…
Two decades after tainted-blood inquiry, new blood donation rules take effect … – The Province
Two decades after tainted-blood inquiry, new blood donation rules take effect …The ProvinceA man gives blood in Montreal, on November 29, 2012. A new blood-donation policy came into effect across Canada on Monday, officially nixing the lifelong ban t…
Antibiotic resistance: The last resort – Nature.com
|
Antibiotic resistance: The last resort
Nature.com CREs cause bladder, lung and blood infections that can spiral into life-threatening septic shock. They evade the action of almost all antibiotics — including the carbapenems, which are considered drugs of last resort — and they kill up to half of all … |
Search for herbal cure for viral fevers – The Hindu
Search for herbal cure for viral feversThe HinduThe second phase will focus on inter-institutional collaboration to apply system biology at different levels, namely cell, tissue, organ, organism and system. Dr. S.R. Suja, Scientist, JNTBGRI will be the…
Knowledge About Infection is the Only Predictor of Treatment in Patients With … – Medscape
|
Knowledge About Infection is the Only Predictor of Treatment in Patients With …
Medscape Long-term improvement in health-related quality of life after orthotopic liver transplantation. Liver Transpl 2008; 14(10): 1404–1145. Kowdely K, Lawitz E et al. GS- 7977 + PEG/RBV in HCV Genotype 1: the ATOMIC Trial An End To Response-Guided Therapy. |